Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01071226 · ClinicalTrials.gov registry record · NA
Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01071226 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 60 participants.
The verdict
NCT01071226, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
T cell depletion utilizing the CliniMACS device will allow more precise, specific and controlled graft engineering of peripheral blood stem cells from unrelated and partially matched related donors without an increase in relapse or graft rejection and grade III or IV acute graft versus host disease (GVHD).
Interventions
- DEVICE CliniMACS (CD+3, CD+19 depletion)
- DEVICE CliniMACS (CD 34+ positive selection)
- OTHER HSCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-05 |
| Est. Completion | 2020-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01071226
The ClinicalTrials.gov registry entry for NCT01071226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CliniMACS (CD+3, CD+19 depletion) is the first listed.
NCT01071226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01071226 about?
NCT01071226 is a clinical study titled "Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device". T cell depletion utilizing the CliniMACS device will allow more precise, specific and controlled graft engineering of peripheral blood stem cells from unrelated and partially matched related donors without an increase in relapse or graft rejection and grade III or IV acute graft versus host disease ...
What is the current status of trial NCT01071226?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2008-05. Estimated completion is 2020-04-28.
What interventions are being tested in trial NCT01071226?
The interventions under investigation include: CliniMACS (CD+3, CD+19 depletion) (DEVICE), CliniMACS (CD 34+ positive selection) (DEVICE), HSCT (OTHER).
Who is sponsoring clinical trial NCT01071226?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.